1. Home
  2. LFST vs HAE Comparison

LFST vs HAE Comparison

Compare LFST & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeStance Health Group Inc.

LFST

LifeStance Health Group Inc.

HOLD

Current Price

$10.88

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$79.91

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFST
HAE
Founded
2015
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
LFST
HAE
Price
$10.88
$79.91
Analyst Decision
Strong Buy
Buy
Analyst Count
6
9
Target Price
$9.83
$84.13
AVG Volume (30 Days)
3.4M
566.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
$1,424,285,000.00
$910,373,000.00
Revenue This Year
$17.18
N/A
Revenue Next Year
$14.02
$5.23
P/E Ratio
N/A
$38.43
Revenue Growth
13.85
N/A
52 Week Low
$3.74
$47.32
52 Week High
$11.76
$87.32

Technical Indicators

Market Signals
Indicator
LFST
HAE
Relative Strength Index (RSI) 59.10 66.26
Support Level $6.23 $78.87
Resistance Level $11.69 $80.60
Average True Range (ATR) 0.37 2.26
MACD -0.12 0.03
Stochastic Oscillator 43.38 96.07

Price Performance

Historical Comparison
LFST
HAE

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: